Alterity Therapeutics Ltd.ASX: ATH

Alterity to Present at Cantor Global Healthcare Conference

· Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Alterity Therapeutics announced its participation in a Fireside Chat at the Cantor Global Healthcare Conference. David Stamler, the CEO, will speak at the event scheduled for a specific time in the United States. The company focuses on developing treatments for neurodegenerative diseases, particularly Multiple System Atrophy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 3 September 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...

Alterity Therapeutics Ltd. on 6ix

Story so far

Earlier from Alterity Therapeutics

Later from Alterity Therapeutics

All Alterity Therapeutics news releases